Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-10-05Clinical Trial Update: Psychosocial Outcomes and Contralateral Prophylactic Mastectomy (CPM)
An update on a breast cancer trial reports psychosocial outcomes and contralateral prophylactic mastectomy; results were posted on 2020-10-0…
-
EMA safety_alert · 2020-10-01EMA reminds physicians to use Tecentriq with nab-paclitaxel for treating breast cancer
EMA reminds physicians to use Tecentriq (atezolizumab) in combination with nab-paclitaxel for treating certain breast cancer indications, hi…
-
CLINICAL_TRIALS trial_result · 2020-10-01Clinical Trial Update: Letrozole and Metronomic Capecitabine in ER-positive HER2 Negative Advanced Breast Cancer (B-001 Study) [Phase 2]
Phase 2 clinical trial update evaluating letrozole with metronomic capecitabine in ER-positive, HER2-negative advanced/metastatic breast can…
-
CLINICAL_TRIALS trial_result · 2020-09-30Clinical Trial Update: Durvalumab and Endocrine Therapy in ER+/Her2- Breast Cancer After CD8+ Infiltration Effective Immune-Attractant Exposure [Phase 2]
Phase 2 trial evaluating durvalumab in combination with endocrine therapy for ER+/HER2- breast cancer after an immune-attractant exposure; s…
-
FDA approval · 2020-09-29FDA Approved: LAPATINIB — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approves Lupin Pharmaceuticals' original ANDA for Lapatinib, a generic version used in treating breast cancer.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-09-28Clinical Trial Update: A Study of Tucatinib vs. Placebo in Combination With Capecitabine & Trastuzumab in Patients With Advanced HER2+ Breast Cancer [Phase 2]
Phase 2 trial evaluating tucatinib with capecitabine and trastuzumab in advanced HER2-positive breast cancer has completed with results post…
-
FDA approval · 2020-09-27FDA Approved: KADCYLA — Supplemental Application (Genentech, Inc.)
FDA approved a supplemental application for KADCYLA (ado-trastuzumab emtansine) submitted by Genentech, Inc.
-
CLINICAL_TRIALS trial_result · 2020-09-25Clinical Trial Update: A Study of Pertuzumab in Combination With Trastuzumab (Herceptin) and a Taxane in First-Line Treatment in Participants With Human Epidermal Growth Factor 2 (HER2)-Positive Advanced Breast Cancer [Phase 3]
A Phase 3 trial evaluating pertuzumab in combination with trastuzumab and a taxane as first-line therapy for HER2-positive advanced breast c…
-
CLINICAL_TRIALS trial_result · 2020-09-25Clinical Trial Update: A Phase II Clinical Trial of PM01183 in BRCA 1/2-Associated or Unselected Metastatic Breast Cancer [Phase 2]
Phase II trial update for PM01183 in BRCA1/2-associated or unselected metastatic breast cancer; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-09-24Clinical Trial Update: Trial of Paclitaxel, Bevacizumab, and Enzastaurin Versus Paclitaxel, Bevacizumab and Placebo for Breast Cancer [Phase 2]
A Phase 2 trial comparing paclitaxel and bevacizumab with enzastaurin versus paclitaxel and bevacizumab with placebo for breast cancer has b…
-
CLINICAL_TRIALS trial_result · 2020-09-23Clinical Trial Update: Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer [Phase 3]
A Phase 3 trial assessed adding trastuzumab to chemotherapy after surgery in women with invasive breast cancer; results have been posted.
-
CLINICAL_TRIALS trial_result · 2020-09-23Clinical Trial Update: Exemestane in Treating Postmenopausal Women With Stage IV Breast Cancer [Phase 2]
Phase 2 trial evaluating exemestane in postmenopausal women with stage IV breast cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-09-22Clinical Trial Update: The Effect of Metformin on Breast Cancer Patients [Phase 2]
Phase 2 clinical trial evaluating the effect of metformin in breast cancer patients.
-
CLINICAL_TRIALS trial_result · 2020-09-21Clinical Trial Update: A Phase II Study to Assess the Efficacy and Safety of SC10914 in the Metastatic Breast Cancer Patients [Phase 2]
Phase II study evaluating SC10914 for metastatic breast cancer with BRCA mutations; results not yet reported.
-
CLINICAL_TRIALS trial_result · 2020-09-21Clinical Trial Update: Mucoadhesive Oral Wound Rinse in Preventing and Treating Stomatitis in Patients With ER- or PR-Positive Metastatic or Locally Recurrent Breast Cancer That Cannot be Removed by Surgery Receiving Everolimus [Phase 2]
Phase 2 clinical trial evaluating a mucoadhesive oral wound rinse to prevent and treat stomatitis in patients with ER- or PR-positive metast…
-
CLINICAL_TRIALS trial_result · 2020-09-18Clinical Trial Update: Trial for Locally Advanced Breast Cancer Using Vorinostat Plus Chemotherapy [Phase 1, Phase 2]
Phase 1/2 trial evaluating vorinostat combined with chemotherapy for locally advanced breast cancer completed; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-09-17Clinical Trial Update: Phase 2 Study of the Monoclonal Antibody MGAH22 (Margetuximab) in Patients With Relapsed or Refractory Advanced Breast Cancer [Phase 2]
Phase 2 study of the monoclonal antibody MGAH22 (margetuximab) in relapsed or refractory advanced breast cancer has completed, and results w…
-
CLINICAL_TRIALS trial_result · 2020-09-16Clinical Trial Update: Survivorship Promotion In Reducing IGF-1 Trial [Phase 2]
Phase 2 trial evaluating survivorship promotion by reducing IGF-1 has completed, with results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-09-16Clinical Trial Update: Trial of Active Immunotherapy With Globo H-KLH (OPT-822) in Metastatic Breast Cancer Subjects [Phase 2]
Phase 2 trial of Globo H-KLH (OPT-822) active immunotherapy in metastatic breast cancer completed.
-
CLINICAL_TRIALS withdrawal · 2020-09-16Clinical Trial Update: Serratus Anterior Muscle Plane Block vsThoracic Paravertebral Block For Unilateral Mastectomies [Phase 4]
Phase 4 trial comparing serratus anterior muscle plane block to thoracic paravertebral block for unilateral mastectomies has been withdrawn.
-
FDA approval · 2020-09-10FDA Approved: DOCETAXEL — Supplemental Application (Mylan Institutional LLC)
FDA approved a supplemental application for a generic docetaxel product (docetaxel anhydrous) from Mylan Institutional LLC.
-
CLINICAL_TRIALS trial_result · 2020-09-10Clinical Trial Update: BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus Bevacizumab [Phase 3]
Phase 3 trial comparing chemotherapy plus trastuzumab versus chemotherapy plus trastuzumab plus bevacizumab in HER2-positive breast cancer w…
-
CLINICAL_TRIALS trial_result · 2020-09-09Clinical Trial Update: OMT-111 for Terminal Stage Solid Tumors [Phase 2]
Phase 2 trial update for OMT-111 in terminal-stage solid tumors including breast and pancreatic cancer.
-
CLINICAL_TRIALS trial_result · 2020-09-07Clinical Trial Update: Define the Optimal Uptake Time of 68Ga-OPS202 When Used as a PET (Positron Emission Tomography) Imaging Agent in Subjects With Newly Diagnosed Breast Cancer [Phase 2]
Phase 2 clinical trial investigating the optimal uptake time of 68Ga-OPS202 as a PET imaging agent in newly diagnosed breast cancer; study s…
-
CLINICAL_TRIALS trial_result · 2020-09-04Clinical Trial Update: Comparison of One-port and Two-port Tissue Expanders for Breast Reconstruction [NA]
A completed clinical trial comparing one-port versus two-port tissue expanders for breast reconstruction in breast cancer patients; results …